Gerd Hanekamp – författare

Almost every energy scenario assumes an enormous growth in the demand for energy in the coming decades. Meanwhile, at international conferences and other venues, the primary concern is massive reduction of greenhouse gas emissions, especially of the CO2 produced by fossil-fuel energy consumption. Experts also point out the political risk of depending on petroleum and remind us of the fact that resources are not inexhaustible. This timely book explores: how these conflicting scenarios could be reconciled; how can we shape a more sustainable energy system from the existing one; and possible technological progress and innovations to enable a brighter future. It also addresses the reality that there exists no consensus on the extent to which innovations can really contribute to reconciling ever-growing energy consumption, availability of resources and the environment, and the structural demands on any energy system.

Firms that operate in a market economy often depend upon innovations in order to achieve competitive advantages that sustainably secure their survival. Business ethics is thus largely concerned with questions about the decisional freedoms involved in innovation processes. Innovations oftentimes raise novel questions about the role of the state or the structure of society. Business ethics needs to provide a framework for balancing the different perspectives, values, and interests at stake. This balance must be achieved at the level of the firm in order to facilitate adequate long term decisions, but it should also be sought at higher, including regulatory, levels. Achieving this balance will require an ethical framework for entrepreneurial action. The particular disciplines engaged in generating innovations as well as all relevant fields of applied ethics should be involved in the balancing process. Business Ethics of Innovation is thus necessarily an interdisciplinary endeavour. This volume assesses general questions of how business ethics can help to structure innovations and specifically discusses pharmaceutical innovations as well as innovations in the IT sector.